Cargando…
Asymptomatic deep vein thromboses in prolonged hospitalized COVID-19 patients
High incidence of venous thromboembolic (VTE) events in coronavirus disease 2019 (COVID-19) patients has been reported despite pharmacologic thromboprophylaxis. We performed prospective bilateral lower extremity ultrasound evaluation of prolonged hospitalized COVID-19 ward patients from our institut...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614081/ https://www.ncbi.nlm.nih.gov/pubmed/34821975 http://dx.doi.org/10.1007/s00508-021-01973-1 |
_version_ | 1784603783158824960 |
---|---|
author | Lucijanic, Marko Piskac Zivkovic, Nevenka Ivic, Marija Sedinic, Martina Brkljacic, Boris Mutvar, Andrea Atic, Armin Rudan, Diana Barsic, Bruno Luksic, Ivica Kusec, Rajko Ivanac, Gordana |
author_facet | Lucijanic, Marko Piskac Zivkovic, Nevenka Ivic, Marija Sedinic, Martina Brkljacic, Boris Mutvar, Andrea Atic, Armin Rudan, Diana Barsic, Bruno Luksic, Ivica Kusec, Rajko Ivanac, Gordana |
author_sort | Lucijanic, Marko |
collection | PubMed |
description | High incidence of venous thromboembolic (VTE) events in coronavirus disease 2019 (COVID-19) patients has been reported despite pharmacologic thromboprophylaxis. We performed prospective bilateral lower extremity ultrasound evaluation of prolonged hospitalized COVID-19 ward patients from our institution without clinical suspicion of deep vein thrombosis (DVT). A total of 102 patient were included in the study. All patients were receiving pharmacologic thromboprophylaxis, the majority in intermediate or therapeutic doses. Asymptomatic DVT was detected in 26/102 (25.5%) patients: 22 had distal and four had proximal DVT, six had bilateral leg involvement. Pulmonary embolism was highly prevalent (17/70, 24.3%) but similarly grouped among patients with and without asymptomatic DVT. In total 37.2% of patients included in the study were recognized as having VTE. Asymptomatic DVT events were more common in intensive care unit (ICU) survivors (60% in postmechanically ventilated ICU survivors, 21.2% in ward patients, 22% in high-flow oxygen treated patients; P = 0.031), in patients with higher modified International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) VTE risk-score (median 3 vs. 2 points with and without DVT; P = 0.021) and higher body temperature on admission (median 38.7 °C vs. 37.7 °C with and without DVT; P = 0.001). No clear associations with Padua VTE risk score, demographic and other clinical characteristics, intensity of thromboprophylaxis, severity of other COVID-19 symptoms, degree of systemic inflammation or D‑dimers on admission were found (P > 0.05 for all analyses). Systematic ultrasound assessment in prolonged hospitalized severe COVID-19 patients prior to hospital discharge is needed, especially in ICU survivors, to timely recognize and appropriately treat patients with asymptomatic DVT. SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00508-021-01973-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-8614081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-86140812021-11-26 Asymptomatic deep vein thromboses in prolonged hospitalized COVID-19 patients Lucijanic, Marko Piskac Zivkovic, Nevenka Ivic, Marija Sedinic, Martina Brkljacic, Boris Mutvar, Andrea Atic, Armin Rudan, Diana Barsic, Bruno Luksic, Ivica Kusec, Rajko Ivanac, Gordana Wien Klin Wochenschr Original Article High incidence of venous thromboembolic (VTE) events in coronavirus disease 2019 (COVID-19) patients has been reported despite pharmacologic thromboprophylaxis. We performed prospective bilateral lower extremity ultrasound evaluation of prolonged hospitalized COVID-19 ward patients from our institution without clinical suspicion of deep vein thrombosis (DVT). A total of 102 patient were included in the study. All patients were receiving pharmacologic thromboprophylaxis, the majority in intermediate or therapeutic doses. Asymptomatic DVT was detected in 26/102 (25.5%) patients: 22 had distal and four had proximal DVT, six had bilateral leg involvement. Pulmonary embolism was highly prevalent (17/70, 24.3%) but similarly grouped among patients with and without asymptomatic DVT. In total 37.2% of patients included in the study were recognized as having VTE. Asymptomatic DVT events were more common in intensive care unit (ICU) survivors (60% in postmechanically ventilated ICU survivors, 21.2% in ward patients, 22% in high-flow oxygen treated patients; P = 0.031), in patients with higher modified International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) VTE risk-score (median 3 vs. 2 points with and without DVT; P = 0.021) and higher body temperature on admission (median 38.7 °C vs. 37.7 °C with and without DVT; P = 0.001). No clear associations with Padua VTE risk score, demographic and other clinical characteristics, intensity of thromboprophylaxis, severity of other COVID-19 symptoms, degree of systemic inflammation or D‑dimers on admission were found (P > 0.05 for all analyses). Systematic ultrasound assessment in prolonged hospitalized severe COVID-19 patients prior to hospital discharge is needed, especially in ICU survivors, to timely recognize and appropriately treat patients with asymptomatic DVT. SUPPLEMENTARY INFORMATION: The online version of this article (10.1007/s00508-021-01973-1) contains supplementary material, which is available to authorized users. Springer Vienna 2021-11-25 2021 /pmc/articles/PMC8614081/ /pubmed/34821975 http://dx.doi.org/10.1007/s00508-021-01973-1 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Original Article Lucijanic, Marko Piskac Zivkovic, Nevenka Ivic, Marija Sedinic, Martina Brkljacic, Boris Mutvar, Andrea Atic, Armin Rudan, Diana Barsic, Bruno Luksic, Ivica Kusec, Rajko Ivanac, Gordana Asymptomatic deep vein thromboses in prolonged hospitalized COVID-19 patients |
title | Asymptomatic deep vein thromboses in prolonged hospitalized COVID-19 patients |
title_full | Asymptomatic deep vein thromboses in prolonged hospitalized COVID-19 patients |
title_fullStr | Asymptomatic deep vein thromboses in prolonged hospitalized COVID-19 patients |
title_full_unstemmed | Asymptomatic deep vein thromboses in prolonged hospitalized COVID-19 patients |
title_short | Asymptomatic deep vein thromboses in prolonged hospitalized COVID-19 patients |
title_sort | asymptomatic deep vein thromboses in prolonged hospitalized covid-19 patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614081/ https://www.ncbi.nlm.nih.gov/pubmed/34821975 http://dx.doi.org/10.1007/s00508-021-01973-1 |
work_keys_str_mv | AT lucijanicmarko asymptomaticdeepveinthrombosesinprolongedhospitalizedcovid19patients AT piskaczivkovicnevenka asymptomaticdeepveinthrombosesinprolongedhospitalizedcovid19patients AT ivicmarija asymptomaticdeepveinthrombosesinprolongedhospitalizedcovid19patients AT sedinicmartina asymptomaticdeepveinthrombosesinprolongedhospitalizedcovid19patients AT brkljacicboris asymptomaticdeepveinthrombosesinprolongedhospitalizedcovid19patients AT mutvarandrea asymptomaticdeepveinthrombosesinprolongedhospitalizedcovid19patients AT aticarmin asymptomaticdeepveinthrombosesinprolongedhospitalizedcovid19patients AT rudandiana asymptomaticdeepveinthrombosesinprolongedhospitalizedcovid19patients AT barsicbruno asymptomaticdeepveinthrombosesinprolongedhospitalizedcovid19patients AT luksicivica asymptomaticdeepveinthrombosesinprolongedhospitalizedcovid19patients AT kusecrajko asymptomaticdeepveinthrombosesinprolongedhospitalizedcovid19patients AT ivanacgordana asymptomaticdeepveinthrombosesinprolongedhospitalizedcovid19patients |